BETAXOLOL HYDROCHLORIDE

BETAXOLOL HYDROCHLORIDE was reported 521 times

BETAXOLOL HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CERVIX ADENOMATOUS POLYP 1 0.2500
1 ORAL MUCOSAL HYPERTROPHY 3 0.1000
2 CORNEAL STAINING 1 0.0909
3 INTERFERON GAMMA LEVEL INCREASED 1 0.0588
4 CORNEAL IRRITATION 2 0.0250
5 DENTAL RESTORATION FAILURE 16 0.0222
6 INTRAOCULAR PRESSURE FLUCTUATION 4 0.0203
7 URINE POTASSIUM DECREASED 1 0.0200
8 CYTOKINE ABNORMAL 1 0.0192
9 CEREBELLAR ISCHAEMIA 3 0.0161
10 CORNEAL ENDOTHELIAL CELL LOSS 1 0.0147
11 WRONG RATE 1 0.0116
12 NASAL DISCHARGE DISCOLOURATION 16 0.0116
13 ANGIOPLASTY 15 0.0100
14 CORNEAL OPERATION 1 0.0097
15 OESOPHAGEAL INTRAMURAL HAEMATOMA 1 0.0095
16 HYPERINSULINISM 1 0.0093
17 PROSTHETIC CARDIAC VALVE THROMBOSIS 1 0.0092
18 WRONG DRUG 3 0.0078
19 URINE SODIUM DECREASED 1 0.0077
20 HELICOBACTER PYLORI IDENTIFICATION TEST POSITIVE 1 0.0070
21 REGRESSIVE BEHAVIOUR 2 0.0069
22 SUBCHORIONIC HAEMORRHAGE 1 0.0068
23 FOETAL GROWTH ABNORMALITY 1 0.0064
24 CREPITATIONS 18 0.0060
25 ACQUIRED HAEMOPHILIA 6 0.0060
26 HAEMOGLOBINAEMIA 1 0.0058
27 CATHETER SITE PAIN 15 0.0058
28 SUBCHORIONIC HAEMATOMA 1 0.0057
29 DIAPHRAGMATIC PARALYSIS 3 0.0050
30 LACTATION INSUFFICIENCY 1 0.0048
31 EMPHYSEMATOUS CYSTITIS 1 0.0047
32 THERMAL BURNS OF EYE 1 0.0044
33 EPIGASTRIC DISCOMFORT 17 0.0043
34 ANGULAR CHEILITIS 3 0.0043
35 NEONATAL SEIZURE 1 0.0040
36 PRODUCT DROPPER ISSUE 3 0.0038
37 REACTION TO PRESERVATIVES 3 0.0037
38 MINERAL DEFICIENCY 1 0.0036
39 PERIPHERAL VASCULAR DISORDER 18 0.0035
40 HEPATITIS B SURFACE ANTIBODY POSITIVE 1 0.0034
41 POSITIVE AIRWAY PRESSURE THERAPY 1 0.0034
42 FEELING HOT AND COLD 1 0.0034
43 XEROPHTHALMIA 2 0.0034
44 RETINOPATHY HYPERTENSIVE 1 0.0033
45 BLOOD BETA-D-GLUCAN INCREASED 1 0.0033
46 PHLEBITIS 16 0.0031
47 HEPATITIS B CORE ANTIBODY POSITIVE 1 0.0027
48 INSTILLATION SITE PRURITUS 1 0.0027
49 CEREBRAL ARTERIOSCLEROSIS 1 0.0026
50 PANCREAS INFECTION 1 0.0025
51 PITUITARY TUMOUR BENIGN 4 0.0025
52 ENCEPHALITIS 16 0.0023
53 NEUROMA 1 0.0022
54 POST INFLAMMATORY PIGMENTATION CHANGE 1 0.0022
55 PUNCTATE KERATITIS 2 0.0022
56 SOFT TISSUE MASS 1 0.0022
57 DIABETIC METABOLIC DECOMPENSATION 3 0.0022
58 HYPERAESTHESIA 17 0.0021
59 TYPE V HYPERLIPIDAEMIA 1 0.0021
60 DEVICE RELATED THROMBOSIS 2 0.0020
61 INTERVERTEBRAL DISC COMPRESSION 2 0.0019
62 SPUTUM DISCOLOURED 18 0.0019
63 ALBUMINURIA 1 0.0019
64 CORNEAL EROSION 1 0.0019
65 CARDIAC PROCEDURE COMPLICATION 1 0.0016
66 MUCOSAL DISCOLOURATION 1 0.0016
67 POOR VENOUS ACCESS 16 0.0015
68 MUCOSAL DRYNESS 3 0.0015
69 HAND DERMATITIS 1 0.0014
70 CUSHING'S SYNDROME 1 0.0014
71 PROCTITIS 4 0.0014
72 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
73 PRODUCT DESIGN ISSUE 1 0.0014
74 LIP EROSION 1 0.0014
75 PULMONARY CONGESTION 18 0.0014
76 CONJUNCTIVITIS ALLERGIC 2 0.0013
77 STATUS EPILEPTICUS 15 0.0013
78 GLAUCOMA 25 0.0013
79 NEUROLOGICAL DECOMPENSATION 3 0.0013
80 EYE ALLERGY 2 0.0013
81 BREAST FEEDING 1 0.0013
82 PERIORBITAL HAEMATOMA 1 0.0012
83 SKIN LACERATION 13 0.0012
84 HEPATITIS A 1 0.0012
85 INTRAOCULAR PRESSURE INCREASED 15 0.0012
86 VITAL FUNCTIONS ABNORMAL 1 0.0012
87 AXONAL NEUROPATHY 1 0.0011
88 FIBRIN D DIMER INCREASED 4 0.0011
89 BLOOD ALBUMIN INCREASED 1 0.0011
90 INTRA-ABDOMINAL FLUID COLLECTION 2 0.0011
91 LIMB INJURY 30 0.0011
92 WOUND 30 0.0011
93 PULSE ABSENT 5 0.0011
94 PYURIA 1 0.0010
95 CARDIAC ANEURYSM 1 0.0010
96 ULCER 16 0.0010
97 PRODUCT DIFFICULT TO SWALLOW 1 0.0010
98 EYE COLOUR CHANGE 1 0.0010
99 PRODUCT CLOSURE REMOVAL DIFFICULT 1 0.0010
100 SOPOR 13 0.0010
101 CONJUNCTIVAL OEDEMA 1 0.0010
102 INFUSION SITE DISCOMFORT 1 0.0010
103 FOREIGN BODY SENSATION IN EYES 6 0.0009
104 CHOKING 18 0.0009
105 UTERINE PROLAPSE 1 0.0009
106 MIDDLE INSOMNIA 17 0.0009
107 DIABETIC NEPHROPATHY 2 0.0009
108 STEVENS-JOHNSON SYNDROME 20 0.0009
109 ESSENTIAL TREMOR 1 0.0009
110 ADENOCARCINOMA 2 0.0009
111 PANCREATITIS NECROTISING 2 0.0009
112 FOLATE DEFICIENCY 1 0.0009
113 ACUTE PRERENAL FAILURE 1 0.0009
114 TRANSIENT ISCHAEMIC ATTACK 29 0.0009
115 ERYTHEMA NODOSUM 3 0.0009
116 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
117 PRODUCT CONTAMINATION MICROBIAL 1 0.0008
118 ESCHERICHIA TEST POSITIVE 1 0.0008
119 OTITIS EXTERNA 1 0.0008
120 ORAL MUCOSA EROSION 1 0.0008
121 BLOOD PRESSURE SYSTOLIC ABNORMAL 2 0.0008
122 ALLERGY TO CHEMICALS 1 0.0008
123 BRADYCARDIA NEONATAL 1 0.0008
124 TRISOMY 21 1 0.0008
125 BLOOD PRESSURE DIASTOLIC ABNORMAL 2 0.0008
126 OESOPHAGEAL HAEMORRHAGE 1 0.0008
127 BLEPHARITIS 3 0.0007
128 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
129 SKIN DEPIGMENTATION 1 0.0007
130 AORTIC DISSECTION 3 0.0007
131 BILIARY DILATATION 1 0.0007
132 SKIN STRIAE 1 0.0007
133 CORONARY ARTERY DISEASE 20 0.0007
134 PRODUCT AVAILABILITY ISSUE 15 0.0007
135 FIBROMYALGIA 16 0.0007
136 MANTLE CELL LYMPHOMA 1 0.0007
137 BOWEL MOVEMENT IRREGULARITY 5 0.0007
138 FIBROSIS 2 0.0006
139 ACUTE MYOCARDIAL INFARCTION 19 0.0006
140 HYPOTONIA NEONATAL 1 0.0006
141 CARDIAC TAMPONADE 3 0.0006
142 GLYCOSYLATED HAEMOGLOBIN DECREASED 1 0.0006
143 HYPOGLYCAEMIA NEONATAL 1 0.0006
144 SHOULDER FRACTURE 1 0.0006
145 METABOLIC SYNDROME 1 0.0006
146 BRADYARRHYTHMIA 1 0.0006
147 EYE IRRITATION 35 0.0006
148 LISTLESS 2 0.0006
149 URINARY RETENTION 20 0.0006
150 VEIN RUPTURE 1 0.0006
151 DIFFICULTY IN WALKING 2 0.0006
152 OVERWEIGHT 3 0.0006
153 DRUG LEVEL BELOW THERAPEUTIC 3 0.0005
154 CATHETER PLACEMENT 1 0.0005
155 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
156 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 2 0.0005
157 COMMUNICATION DISORDER 2 0.0005
158 OCULAR HYPERTENSION 1 0.0005
159 ATROPHY 1 0.0005
160 HEART RATE DECREASED 18 0.0005
161 HYPOGEUSIA 1 0.0005
162 FUNGAL INFECTION 17 0.0005
163 PANIC ATTACK 18 0.0005
164 EYELID PAIN 1 0.0005
165 BLINDNESS 20 0.0005
166 TONGUE BITING 1 0.0005
167 VENOUS THROMBOSIS LIMB 1 0.0005
168 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
169 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
170 FACIAL PALSY 1 0.0005
171 COMA 22 0.0005
172 CORNEAL DISORDER 1 0.0005
173 PRODUCT FORMULATION ISSUE 3 0.0005
174 ARTERIOSCLEROSIS CORONARY ARTERY 3 0.0005
175 SPINAL COLUMN INJURY 1 0.0004
176 PRODUCT PACKAGE ASSOCIATED INJURY 1 0.0004
177 PULMONARY OEDEMA 20 0.0004
178 INFECTIOUS MONONUCLEOSIS 1 0.0004
179 CHRONIC GASTRITIS 1 0.0004
180 BLOOD PRESSURE SYSTOLIC DECREASED 2 0.0004
181 EYELID DISORDER 1 0.0004
182 MENOPAUSAL SYMPTOMS 1 0.0004
183 UTERINE DISORDER 1 0.0004
184 DUODENAL ULCER 3 0.0004
185 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 1 0.0004
186 URINE FLOW DECREASED 1 0.0004
187 HYPOVOLAEMIC SHOCK 2 0.0004
188 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
189 STAPHYLOCOCCAL SEPSIS 2 0.0004
190 INSTILLATION SITE PAIN 1 0.0004
191 DEVICE INFUSION ISSUE 1 0.0004
192 HEART INJURY 1 0.0004
193 HEPATIC ENZYME ABNORMAL 2 0.0004
194 TACHYARRHYTHMIA 1 0.0004
195 VASODILATATION 1 0.0004
196 DRUG TOLERANCE 2 0.0004
197 ABDOMINAL INFECTION 1 0.0004
198 AORTIC ARTERIOSCLEROSIS 1 0.0004
199 HYPERSENSITIVITY VASCULITIS 1 0.0004
200 DEPRESSED LEVEL OF CONSCIOUSNESS 15 0.0004
201 PRODUCTIVE COUGH 18 0.0004
202 PROTEIN TOTAL INCREASED 1 0.0004
203 ANGIONEUROTIC OEDEMA 1 0.0004
204 CARDIAC FAILURE CONGESTIVE 30 0.0004
205 MYCOBACTERIUM AVIUM COMPLEX INFECTION 1 0.0004
206 CHONDROPATHY 1 0.0004
207 LARGE INTESTINAL ULCER 1 0.0004
208 ULCERATIVE KERATITIS 1 0.0004
209 PRODUCT PHYSICAL CONSISTENCY ISSUE 2 0.0004
210 THROAT IRRITATION 16 0.0004
211 PRODUCT LEAKAGE 2 0.0004
212 BLINDNESS UNILATERAL 5 0.0004
213 EYE PAIN 20 0.0004
214 PANCREATIC CARCINOMA METASTATIC 1 0.0004
215 PRODUCT CONTAINER ISSUE 3 0.0003
216 HEART VALVE INCOMPETENCE 1 0.0003
217 EYELID MARGIN CRUSTING 1 0.0003
218 THERAPEUTIC REACTION TIME DECREASED 1 0.0003
219 THORACIC VERTEBRAL FRACTURE 1 0.0003
220 WHEEZING 20 0.0003
221 ISCHAEMIC STROKE 6 0.0003
222 ATYPICAL PNEUMONIA 1 0.0003
223 LUNG ADENOCARCINOMA 1 0.0003
224 HYPERCAPNIA 1 0.0003
225 CEREBROVASCULAR DISORDER 1 0.0003
226 CRANIOCEREBRAL INJURY 1 0.0003
227 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
228 PRODUCT DISPENSING ERROR 7 0.0003
229 FOREIGN BODY IN THROAT 1 0.0003
230 INFUSION SITE PRURITUS 1 0.0003
231 POISONING DELIBERATE 3 0.0003
232 ASTHMA 35 0.0003
233 RHINORRHOEA 20 0.0003
234 PHARYNGEAL SWELLING 3 0.0003
235 LYMPHOCYTE COUNT INCREASED 1 0.0003
236 HAEMORRHAGE 32 0.0003
237 NEAR DEATH EXPERIENCE 1 0.0003
238 SALIVARY HYPERSECRETION 3 0.0003
239 EMPHYSEMA 3 0.0003
240 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 21 0.0003
241 ABNORMAL LOSS OF WEIGHT 2 0.0003
242 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5 0.0003
243 RETINAL HAEMORRHAGE 2 0.0003
244 PRODUCT SUPPLY ISSUE 2 0.0003
245 BREAST CANCER METASTATIC 3 0.0003
246 THROMBOCYTOSIS 1 0.0003
247 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
248 PARADOXICAL DRUG REACTION 1 0.0003
249 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
250 BLOOD PRESSURE DECREASED 18 0.0003
251 PAROSMIA 2 0.0003
252 FACE INJURY 1 0.0003
253 OESOPHAGEAL ULCER 1 0.0003
254 LOW DENSITY LIPOPROTEIN INCREASED 2 0.0003
255 POLYDIPSIA 1 0.0003
256 SUSPECTED COUNTERFEIT PRODUCT 1 0.0003
257 CHOLECYSTITIS 3 0.0003
258 CEREBRAL ATROPHY 1 0.0003
259 MUSCLE RIGIDITY 3 0.0003
260 AZOTAEMIA 1 0.0003
261 FOREIGN BODY 1 0.0002
262 ORGAN FAILURE 1 0.0002
263 TACHYCARDIA 22 0.0002
264 GOITRE 1 0.0002
265 CHEST DISCOMFORT 25 0.0002
266 HYPERURICAEMIA 1 0.0002
267 INFUSION RELATED REACTION 16 0.0002
268 CONGESTIVE CARDIOMYOPATHY 1 0.0002
269 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
270 CARDIAC FAILURE CHRONIC 1 0.0002
271 INTERVERTEBRAL DISC DISORDER 1 0.0002
272 DYSPEPSIA 23 0.0002
273 PRODUCT DISPENSING ISSUE 1 0.0002
274 BRONCHITIS 17 0.0002
275 DIVERTICULUM INTESTINAL 1 0.0002
276 NAIL DISORDER 2 0.0002
277 HOT FLUSH 17 0.0002
278 EYE HAEMORRHAGE 3 0.0002
279 SWELLING 21 0.0002
280 UVEITIS 3 0.0002
281 SYNCOPE 22 0.0002
282 LUMBAR VERTEBRAL FRACTURE 1 0.0002
283 PERFORMANCE STATUS DECREASED 1 0.0002
284 OEDEMA PERIPHERAL 26 0.0002
285 PHOTOPHOBIA 4 0.0002
286 THROMBOSIS 17 0.0002
287 MUSCULAR WEAKNESS 24 0.0002
288 COLITIS MICROSCOPIC 1 0.0002
289 OCULAR HYPERAEMIA 10 0.0002
290 EYE INFLAMMATION 2 0.0002
291 SUPRAVENTRICULAR TACHYCARDIA 2 0.0002
292 PULMONARY FIBROSIS 4 0.0002
293 BLOOD PRESSURE FLUCTUATION 5 0.0002
294 BRADYCARDIA 11 0.0002
295 HUMERUS FRACTURE 1 0.0002
296 HYPERCHOLESTEROLAEMIA 2 0.0002
297 HEPATOMEGALY 2 0.0002
298 ARTHRITIS 16 0.0002
299 BODY TEMPERATURE DECREASED 2 0.0002
300 PANCREATIC DISORDER 1 0.0002
301 INFLAMMATORY MARKER INCREASED 1 0.0002
302 GASTROINTESTINAL SOUNDS ABNORMAL 1 0.0002
303 MULTIPLE DRUG OVERDOSE 1 0.0002
304 ABDOMINAL TENDERNESS 1 0.0002
305 FALL 67 0.0002
306 ANEURYSM 1 0.0002
307 PULMONARY EMBOLISM 19 0.0002
308 VEIN DISORDER 1 0.0002
309 ERYSIPELAS 1 0.0002
310 CORONARY ARTERY STENOSIS 1 0.0002
311 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
312 HAEMOGLOBIN DECREASED 20 0.0002
313 ERECTILE DYSFUNCTION 5 0.0002
314 FOOD CRAVING 1 0.0002
315 BLOOD LACTIC ACID INCREASED 1 0.0002
316 POOR QUALITY PRODUCT ADMINISTERED 2 0.0002
317 PRODUCT SIZE ISSUE 1 0.0002
318 PRODUCT RESIDUE PRESENT 1 0.0002
319 ERYTHEMA OF EYELID 1 0.0002
320 VISUAL ACUITY REDUCED 6 0.0002
321 FOOT DEFORMITY 2 0.0002
322 TYPE 2 DIABETES MELLITUS 6 0.0002
323 OCULAR DISCOMFORT 2 0.0002
324 PERIORBITAL SWELLING 1 0.0002
325 METASTASES TO LUNG 2 0.0002
326 SOCIAL AVOIDANT BEHAVIOUR 1 0.0002
327 HYPERVENTILATION 1 0.0002
328 EYELID OEDEMA 2 0.0002
329 SPINAL PAIN 2 0.0002
330 ENERGY INCREASED 1 0.0002
331 CATARACT 10 0.0002
332 ADVERSE DRUG REACTION 15 0.0002
333 HYPERSENSITIVITY 31 0.0002
334 GANGRENE 1 0.0002
335 SINUSITIS 17 0.0002
336 SQUAMOUS CELL CARCINOMA OF SKIN 1 0.0002
337 ADRENAL INSUFFICIENCY 2 0.0002
338 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0002
339 TENSION 1 0.0002
340 INJECTION SITE EXTRAVASATION 2 0.0002
341 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
342 INFUSION SITE EXTRAVASATION 1 0.0002
343 NASAL DRYNESS 1 0.0002
344 SWELLING OF EYELID 1 0.0002
345 INFUSION SITE SWELLING 1 0.0002
346 CHOLESTASIS 3 0.0002
347 CARDIAC FLUTTER 1 0.0002
348 EAR PAIN 3 0.0002
349 HEPATITIS ACUTE 1 0.0002
350 DRUG SPECIFIC ANTIBODY PRESENT 1 0.0002
351 KIDNEY INFECTION 3 0.0002
352 EYE DISORDER 5 0.0002
353 CARDIAC DISORDER 14 0.0001
354 CYTOKINE RELEASE SYNDROME 3 0.0001
355 LEFT VENTRICULAR DYSFUNCTION 1 0.0001
356 MYOCARDIAL INFARCTION 26 0.0001
357 BONE MARROW FAILURE 3 0.0001
358 PULMONARY HYPERTENSION 3 0.0001
359 AUTOIMMUNE HEPATITIS 1 0.0001
360 FORMICATION 1 0.0001
361 EXTRASYSTOLES 1 0.0001
362 RIGHT VENTRICULAR FAILURE 1 0.0001
363 PAPULE 1 0.0001
364 SEASONAL ALLERGY 2 0.0001
365 LIVER FUNCTION TEST INCREASED 3 0.0001
366 ELECTROCARDIOGRAM QT PROLONGED 5 0.0001
367 BLOOD CREATINE PHOSPHOKINASE INCREASED 4 0.0001
368 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
369 VISUAL FIELD DEFECT 1 0.0001
370 ANOSMIA 2 0.0001
371 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
372 CHILLS 16 0.0001
373 SENSITIVE SKIN 1 0.0001
374 ARTHROPOD BITE 1 0.0001
375 TRANSAMINASES INCREASED 3 0.0001
376 HYPOAESTHESIA 20 0.0001
377 CHROMATURIA 3 0.0001
378 PEMPHIGOID 1 0.0001
379 LACRIMATION INCREASED 4 0.0001
380 TROPONIN INCREASED 1 0.0001
381 ATRIOVENTRICULAR BLOCK 1 0.0001
382 CONCUSSION 1 0.0001
383 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
384 APNOEA 1 0.0001
385 ACUTE MYELOID LEUKAEMIA 2 0.0001
386 THERAPY PARTIAL RESPONDER 2 0.0001
387 PNEUMOTHORAX 2 0.0001
388 ATRIAL FLUTTER 1 0.0001
389 FRUSTRATION TOLERANCE DECREASED 1 0.0001
390 SHOCK HAEMORRHAGIC 1 0.0001
391 DECUBITUS ULCER 1 0.0001
392 POLYURIA 1 0.0001
393 METASTASES TO BONE 2 0.0001
394 SECOND PRIMARY MALIGNANCY 1 0.0001
395 RHABDOMYOLYSIS 5 0.0001
396 BLOOD UREA INCREASED 2 0.0001
397 EYE PRURITUS 4 0.0001
398 INFUSION SITE ERYTHEMA 1 0.0001
399 VITAMIN D DECREASED 1 0.0001
400 MYOPATHY 1 0.0001
401 ORTHOSTATIC HYPOTENSION 2 0.0001
402 TREMOR 19 0.0001
403 URINE OUTPUT DECREASED 1 0.0001
404 NASOPHARYNGITIS 21 0.0001
405 SPINAL OSTEOARTHRITIS 1 0.0001
406 DEPRESSED MOOD 6 0.0001
407 BLOOD TRIGLYCERIDES INCREASED 2 0.0001
408 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
409 PURPURA 1 0.0001
410 JAUNDICE 3 0.0001
411 C-REACTIVE PROTEIN INCREASED 4 0.0001
412 PNEUMONIA BACTERIAL 1 0.0001
413 OVARIAN CANCER 1 0.0001
414 UROSEPSIS 1 0.0001
415 DYSPNOEA 61 0.0001
416 HEPATIC STEATOSIS 2 0.0001
417 PANCYTOPENIA 6 0.0001
418 ERYTHEMA MULTIFORME 1 0.0001
419 NEPHROPATHY 1 0.0001
420 DYSPNOEA EXERTIONAL 4 0.0001
421 FRACTURE 2 0.0001
422 ANGINA PECTORIS 3 0.0001
423 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
424 BLADDER DISORDER 1 0.0001
425 UPPER LIMB FRACTURE 2 0.0001
426 LEUKOPENIA 5 0.0001
427 CARDIAC FAILURE 8 0.0001
428 HYPOTHERMIA 1 0.0001
429 DYSKINESIA 4 0.0001
430 BODY TEMPERATURE INCREASED 2 0.0001
431 ABDOMINAL PAIN UPPER 20 0.0001
432 GYNAECOMASTIA 3 0.0001
433 HYPERBILIRUBINAEMIA 1 0.0001
434 EYE DISCHARGE 1 0.0001
435 VISION BLURRED 13 0.0001
436 HYPOTHYROIDISM 3 0.0001
437 WEIGHT INCREASED 21 0.0001
438 BREAST PAIN 1 0.0001
439 JOINT INJURY 2 0.0001
440 COUGH 26 0.0001
441 DECREASED ACTIVITY 1 0.0001
442 PRURITUS GENERALISED 2 0.0001
443 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
444 TREATMENT NONCOMPLIANCE 5 0.0001
445 BACK PAIN 21 0.0001
446 EXPIRED PRODUCT ADMINISTERED 3 0.0001
447 MEDICATION ERROR 5 0.0001
448 HYPERTENSIVE CRISIS 1 0.0001
449 ORAL PAIN 2 0.0001
450 INTESTINAL PERFORATION 1 0.0001
451 PANCREATITIS ACUTE 2 0.0001
452 HEART RATE IRREGULAR 2 0.0001
453 MITRAL VALVE INCOMPETENCE 1 0.0001
454 PAIN IN EXTREMITY 26 0.0001
455 IMPAIRED DRIVING ABILITY 1 0.0001
456 MYOCARDIAL ISCHAEMIA 1 0.0001
457 ANXIETY 25 0.0001
458 DERMATITIS CONTACT 1 0.0001
459 VASCULITIS 1 0.0001
460 HYPERKALAEMIA 3 0.0001
461 CONTUSION 8 0.0001
462 HYPERGLYCAEMIA 3 0.0001
463 CEREBRAL INFARCTION 2 0.0001
464 ABDOMINAL PAIN 19 0.0001
465 LIVER INJURY 2 0.0001
466 CARDIOMEGALY 1 0.0001
467 SPINAL OPERATION 1 0.0001
468 GENERALISED OEDEMA 1 0.0001
469 ILEUS 1 0.0001
470 POISONING 1 0.0001
471 DERMATITIS ALLERGIC 1 0.0001
472 COLITIS 3 0.0001
473 HAEMATEMESIS 2 0.0001
474 ANAEMIA 15 0.0001
475 INJECTION SITE IRRITATION 1 0.0001
476 ANOREXIA 1 0.0001
477 DEAFNESS 2 0.0001
478 DIZZINESS 38 0.0001
479 PANCREATITIS 4 0.0001
480 DRY MOUTH 6 0.0001
481 DIVERTICULITIS 2 0.0001
482 ATRIAL FIBRILLATION 7 0.0001
483 ACUTE KIDNEY INJURY 11 0.0001
484 HYPOMAGNESAEMIA 1 0.0001
485 OXYGEN SATURATION DECREASED 4 0.0001
486 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
487 RENAL FAILURE ACUTE 3 0.0001
488 HEART RATE INCREASED 7 0.0001
489 MYALGIA 12 0.0001
490 HEPATOCELLULAR INJURY 1 0.0001
491 INTENTIONAL DOSE OMISSION 2 0.0001
492 BRONCHOSPASM 1 0.0001
493 HYPERTHYROIDISM 1 0.0001
494 PNEUMONIA 22 0.0001
495 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
496 SKIN HAEMORRHAGE 1 0.0001
497 PULMONARY MASS 1 0.0001
498 IMMUNODEFICIENCY 1 0.0001
499 HAEMORRHAGE INTRACRANIAL 1 0.0001
500 INSURANCE ISSUE 1 0.0001
501 HYPOKALAEMIA 3 0.0001
502 ARTHRALGIA 27 0.0001
503 HYPOTENSION 13 0.0001
504 MUSCULOSKELETAL CHEST PAIN 1 0.0001
505 ANKLE FRACTURE 1 0.0001
506 MALAISE 28 0.0001
507 PAIN 39 0.0001
508 PRODUCT USE COMPLAINT 1 0.0001
509 ARRHYTHMIA 3 0.0001
510 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
511 NEUROPATHY PERIPHERAL 6 0.0001
512 DISEASE RECURRENCE 3 0.0001
513 HALLUCINATION, AUDITORY 1 0.0001
514 CYSTITIS 2 0.0001
515 OBESITY 1 0.0001
516 SCIATICA 1 0.0001
517 INTERSTITIAL LUNG DISEASE 3 0.0001
518 BLOOD POTASSIUM INCREASED 1 0.0001
519 BLOOD CREATININE INCREASED 4 0.0001
520 CHOLELITHIASIS 2 0.0001
521 PYREXIA 21 0.0001
522 PSYCHOMOTOR HYPERACTIVITY 1 0.0001
523 DRY EYE 3 0.0001
524 GAIT INABILITY 2 0.0001
525 PALPITATIONS 7 0.0001
526 CHEST PAIN 11 0.0001
527 PRODUCT QUALITY ISSUE 8 0.0001
528 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
529 INJECTION SITE PAIN 18 0.0001
530 INFLAMMATION 3 0.0001
531 NIGHTMARE 2 0.0001
532 MUSCULOSKELETAL PAIN 3 0.0001
533 EOSINOPHILIA 1 0.0001
534 INCORRECT DOSE ADMINISTERED 13 0.0001
535 METASTASES TO LIVER 1 0.0001
536 COLD SWEAT 1 0.0001
537 HYPERTENSION 12 0.0001
538 HEAD DISCOMFORT 1 0.0001
539 DIABETES MELLITUS INADEQUATE CONTROL 1 0.0001
540 DRUG ERUPTION 1 0.0001
541 MYELOSUPPRESSION 2 0.0001
542 VOMITING 26 0.0001
543 DRUG EFFECT INCOMPLETE 2 0.0001
544 WRONG TECHNIQUE IN DRUG USAGE PROCESS 2 0.0001
545 ACCIDENTAL OVERDOSE 2 0.0001
546 LOSS OF CONSCIOUSNESS 7 0.0001
547 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 1 0.0001
548 DYSGEUSIA 4 0.0001
549 EYE SWELLING 2 0.0001
550 HEPATIC FUNCTION ABNORMAL 2 0.0001
551 HYPONATRAEMIA 3 0.0001
552 ASTHENIA 20 0.0001
553 HYPOCALCAEMIA 1 0.0001
554 FOOT FRACTURE 1 0.0001
555 RENAL FAILURE 7 0.0001
556 BLOOD URINE PRESENT 1 0.0001
557 FEELING JITTERY 1 0.0001
558 INCREASED APPETITE 1 0.0001
559 BLOOD PRESSURE INCREASED 8 0.0001
560 LETHARGY 3 0.0001
561 DRUG PRESCRIBING ERROR 1 0.0001
562 ACUTE RESPIRATORY FAILURE 1 0.0001
563 DRUG INTOLERANCE 5 0.0001
564 PLASMA CELL MYELOMA 2 0.0001
565 BONE PAIN 3 0.0001
566 SKIN FISSURES 1 0.0001
567 DISEASE PROGRESSION 6 0.0001
568 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
569 SINUS DISORDER 1 0.0001
570 PREGNANCY 1 0.0000
571 PRODUCT PHYSICAL ISSUE 1 0.0000
572 HEADACHE 31 0.0000
573 FEEDING DISORDER 1 0.0000
574 NEUTROPHIL COUNT DECREASED 2 0.0000
575 FEELING HOT 3 0.0000
576 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
577 VISUAL IMPAIRMENT 6 0.0000
578 RASH 21 0.0000
579 DERMATITIS 1 0.0000
580 KNEE ARTHROPLASTY 1 0.0000
581 HALLUCINATION, VISUAL 1 0.0000
582 EATING DISORDER 1 0.0000
583 IMPAIRED WORK ABILITY 1 0.0000
584 PRODUCT DOSE OMISSION 3 0.0000
585 PRODUCT STORAGE ERROR 4 0.0000
586 MUSCULOSKELETAL STIFFNESS 4 0.0000
587 APPLICATION SITE PAIN 1 0.0000
588 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
589 RASH MACULO-PAPULAR 1 0.0000
590 DIARRHOEA 29 0.0000
591 THROMBOCYTOPENIA 5 0.0000
592 PARAESTHESIA 7 0.0000
593 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 8 0.0000
594 DRUG INTERACTION 7 0.0000
595 FATIGUE 34 0.0000
596 SKIN DISCOLOURATION 2 0.0000
597 SHOCK 1 0.0000
598 OROPHARYNGEAL PAIN 4 0.0000
599 RENAL DISORDER 2 0.0000
600 NAUSEA 33 0.0000
601 PRESYNCOPE 1 0.0000
602 ENCEPHALOPATHY 1 0.0000
603 ABASIA 1 0.0000
604 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
605 EPISTAXIS 3 0.0000
606 AGEUSIA 1 0.0000
607 PNEUMONIA ASPIRATION 1 0.0000
608 GLYCOSYLATED HAEMOGLOBIN INCREASED 1 0.0000
609 WEIGHT DECREASED 11 0.0000
610 CARDIOVASCULAR DISORDER 1 0.0000
611 DIABETES MELLITUS 3 0.0000
612 FLUID RETENTION 2 0.0000
613 HYPOPHAGIA 1 0.0000
614 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
615 HAEMATOMA 1 0.0000
616 EXPOSURE VIA SKIN CONTACT 1 0.0000
617 PHARMACEUTICAL PRODUCT COMPLAINT 1 0.0000
618 RESPIRATORY TRACT INFECTION 1 0.0000
619 ANHEDONIA 1 0.0000
620 GASTRITIS 1 0.0000
621 DRUG INEFFECTIVE 50 0.0000
622 PRODUCT DOSE OMISSION ISSUE 11 0.0000
623 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
624 BLOOD BILIRUBIN INCREASED 1 0.0000
625 CARDIAC ARREST 3 0.0000
626 HAEMATOCHEZIA 2 0.0000
627 ABNORMAL DREAMS 1 0.0000
628 PROCEDURAL PAIN 1 0.0000
629 DEMENTIA 1 0.0000
630 RENAL IMPAIRMENT 3 0.0000
631 SKIN EXFOLIATION 3 0.0000
632 FLATULENCE 2 0.0000
633 HYPERSOMNIA 1 0.0000
634 BALANCE DISORDER 3 0.0000
635 DYSSTASIA 1 0.0000
636 INTENTIONAL PRODUCT USE ISSUE 3 0.0000
637 DYSPHONIA 2 0.0000
638 LABORATORY TEST ABNORMAL 1 0.0000
639 RENAL INJURY 1 0.0000
640 THERAPEUTIC RESPONSE DECREASED 2 0.0000
641 ILL-DEFINED DISORDER 2 0.0000
642 PLEURAL EFFUSION 2 0.0000
643 EPILEPSY 1 0.0000
644 DRUG ADMINISTRATION ERROR 1 0.0000
645 LIMB DISCOMFORT 1 0.0000
646 FEMUR FRACTURE 1 0.0000
647 DRUG-INDUCED LIVER INJURY 1 0.0000
648 HEAD INJURY 1 0.0000
649 METABOLIC ACIDOSIS 1 0.0000
650 MOVEMENT DISORDER 1 0.0000
651 HYPERHIDROSIS 4 0.0000
652 NIGHT SWEATS 1 0.0000
653 LACTIC ACIDOSIS 1 0.0000
654 DEEP VEIN THROMBOSIS 2 0.0000
655 DEPRESSION 7 0.0000
656 IMPAIRED HEALING 1 0.0000
657 OSTEONECROSIS 1 0.0000
658 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
659 DECREASED APPETITE 7 0.0000
660 VIRAL INFECTION 1 0.0000
661 DEHYDRATION 4 0.0000
662 SKIN DISORDER 1 0.0000
663 FLUSHING 3 0.0000
664 HEPATIC ENZYME INCREASED 2 0.0000
665 GASTRIC DISORDER 1 0.0000
666 HYPOXIA 1 0.0000
667 THERAPY INTERRUPTED 2 0.0000
668 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
669 RESTLESSNESS 1 0.0000
670 MUSCLE SPASMS 5 0.0000
671 DYSURIA 1 0.0000
672 INFLUENZA 3 0.0000
673 WHITE BLOOD CELL COUNT INCREASED 1 0.0000
674 PERIPHERAL SWELLING 4 0.0000
675 DRUG DEPENDENCE 4 0.0000
676 CONFUSIONAL STATE 4 0.0000
677 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
678 CARDIO-RESPIRATORY ARREST 1 0.0000
679 URINARY TRACT INFECTION 4 0.0000
680 RECTAL HAEMORRHAGE 1 0.0000
681 SEPTIC SHOCK 1 0.0000
682 LIVER DISORDER 1 0.0000
683 INSOMNIA 6 0.0000
684 COLITIS ULCERATIVE 1 0.0000
685 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
686 SKIN IRRITATION 1 0.0000
687 BLOOD GLUCOSE INCREASED 4 0.0000
688 FEELING ABNORMAL 5 0.0000
689 HYPOGLYCAEMIA 1 0.0000
690 PRODUCT USE IN UNAPPROVED INDICATION 5 0.0000
691 AGGRESSION 1 0.0000
692 SOMNOLENCE 4 0.0000
693 CELLULITIS 1 0.0000
694 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 4 0.0000
695 CONDITION AGGRAVATED 6 0.0000
696 ERYTHEMA 4 0.0000
697 ILLNESS 2 0.0000
698 NERVOUSNESS 1 0.0000
699 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
700 DISTURBANCE IN ATTENTION 1 0.0000
701 OEDEMA 1 0.0000
702 CONSTIPATION 4 0.0000
703 OFF LABEL USE 16 0.0000
704 ANAPHYLACTIC REACTION 1 0.0000
705 URTICARIA 3 0.0000
706 NECK PAIN 1 0.0000
707 ABDOMINAL DISCOMFORT 3 0.0000
708 CONVULSION 1 0.0000
709 HERPES ZOSTER 1 0.0000
710 PRODUCT SUBSTITUTION ISSUE 1 0.0000
711 GENERAL PHYSICAL HEALTH DETERIORATION 2 0.0000
712 BLADDER CANCER 1 0.0000
713 STOMATITIS 1 0.0000
714 VERTIGO 1 0.0000
715 DISCOMFORT 1 0.0000
716 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
717 EXPOSURE DURING PREGNANCY 1 0.0000
718 PRODUCT USE ISSUE 3 0.0000
719 AMNESIA 1 0.0000
720 FEBRILE NEUTROPENIA 1 0.0000
721 NEOPLASM MALIGNANT 1 0.0000
722 NEUTROPENIA 2 0.0000
723 MEMORY IMPAIRMENT 2 0.0000
724 INJECTION SITE REACTION 1 0.0000
725 SLEEP DISORDER 1 0.0000
726 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
727 MOBILITY DECREASED 1 0.0000
728 RESPIRATORY FAILURE 1 0.0000
729 UNDERDOSE 1 0.0000
730 AGITATION 1 0.0000
731 HALLUCINATION 1 0.0000
732 UNEVALUABLE EVENT 1 0.0000
733 INJECTION SITE BRUISING 1 0.0000
734 INJECTION SITE HAEMORRHAGE 1 0.0000
735 TREATMENT FAILURE 1 0.0000
736 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
737 COVID-19 2 0.0000
738 GASTROINTESTINAL DISORDER 1 0.0000
739 DEVICE ISSUE 1 0.0000
740 NO ADVERSE EVENT 2 0.0000
741 SUICIDAL IDEATION 1 0.0000
742 DYSPHAGIA 1 0.0000
743 MIGRAINE 1 0.0000
744 GAIT DISTURBANCE 2 0.0000
745 PRURITUS 4 0.0000
746 ABDOMINAL DISTENSION 1 0.0000
747 PLATELET COUNT DECREASED 1 0.0000
748 OVERDOSE 2 0.0000
749 SEPSIS 1 0.0000
750 SEIZURE 1 0.0000
751 INJECTION SITE ERYTHEMA 1 0.0000
752 DRY SKIN 1 0.0000
753 INFECTION 1 0.0000
754 HOSPITALISATION 1 0.0000
755 DRUG DOSE OMISSION 1 0.0000
756 TOXICITY TO VARIOUS AGENTS 1 0.0000
757 CEREBROVASCULAR ACCIDENT 1 0.0000
758 DEATH 5 0.0000
759 ALOPECIA 1 0.0000